An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with numerous of members share comparison images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Experts Express Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to users administering substances of uncertain source.
Some experts stated the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Removal
According to TikTok, the service has removed problematic content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Research also found communities with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.
After minutes of entering one community, a seller posted WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Within these communities, messages show black plastic packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose users to potentially significant health risks”.
